Vetr Issues Strong Buy As Teva Trends Down
May 19, 2017 at 07:30 AM EDT
The Vetr crowd on Thursday upgraded its rating for Teva Pharmaceutical Industries Limited (ADR) (NYSE: TEVA) from 3.5 stars (Buy), ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.